Lilly pens deal with Gateway Labs alumni Amplitude for RNA vaccine platform for infectious disease
Fuente:
FierceBiotech
Eli Lilly has turned to one of its Gateway Labs residents to help the Big Pharma develop trans-amplifying RNA (taRNA) vaccines for infectious diseases.